Vascular quality of care pilot study: How admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease

Vascular Health and Risk Management

Volumn 10, Issue , 2014, Pages 333-340

  Steenhof, Naomi ^a,b   Le Piane, Francesca ^a   Leblanc, Kori ^a,b   Eisenberg, Naomi R ^a   Kwan, Yvonne ^a   Malmberg, Christine ^a,c   Papadopoulos, Alexandra ^b,d   Roche Nagle, Graham ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c VANCOUVER ISLAND HEALTH AUTHORITY   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Guideline adherence; Risk reduction; Vascular protection

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PILOT STUDY; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TEACHING HOSPITAL; TERTIARY CARE CENTER; VASCULAR SURGERY; VERY ELDERLY;

GUIDELINE ADHERENCE; RISK REDUCTION; VASCULAR PROTECTION;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; GUIDELINE ADHERENCE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; ONTARIO; PATIENT ADMISSION; PATIENT DISCHARGE; PERIPHERAL ARTERIAL DISEASE; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84902191576     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S61966     Document Type: Article

References (14)

1. Lovell M, Harris K, Forbes T, et al; Peripheral Arterial Disease Coalition. Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol. 2009;25(1):39-45.
2. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94(11):3026-3049.
3. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol. 2006;47(6):e1-e192.
4. Rooke TW, Hirsch AT, Misra S, et al; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58(19):2020-2045.
5. Abramson BL, Huckell V, Anand S et al. Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease-executive summary. Can J Cardiol. 2005;21(12):997-1006.
6. Bell AD, Roussin A, Cartier R, et al; Canadian Cardiovascular Society. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol. 2011;27 Suppl A: S1-S59.
7. Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation. 2011;124(1):17-23.
8. Pâquet M, Pilon D, Tétrault JP, Carrier N. Protective vascular treatment of patients with peripheral arterial disease: guideline adherence according to year, age and gender. Can J Public Health. 2010;101(1): 96-100.
9. Sunderland M, De Jong M, Bates D. Vascular protection in patients with diabetes admitted for vascular surgery in a canadian tertiary care hospital: pilot study. Can J Hosp Pharm. 2013;66(4):227-232.
10. Coveney AP, O'Brien GC, Fulton GJ. ACE up the sleeve-are vascular patients medically optimized? Vasc Health Risk Manag. 2011;7: 15-21.
11. University Health Network Corporate Intranet. Program Groupings. Peter Munk Cardiac Centre: Vascular Surgery [webpage on the Internet]. Available at: https://intranet.remote.uhn.ca/cvpn/IpAnkAjrG_1etKhCo-f6xl8jmOkD/departm ents/programs/heart/vascular_surgery.asp. Accessed January 19, 2014.
12. CritiCall Ontario [webpage on the Internet]. Available at http://criticall.org. Accessed June 16, 2012.
13. The ONTARGET Investigators; Yusuf S, Teo KK, et al. Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-1559.
14. Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003;107(5):753-756.